Trial intelligence / Profile preview

Ciclosporin A Preconditioning in Renal Artery Stenosis Dilation

NCT03382301Phase 2Completed

Sponsor
Hospices Civils de Lyon
Start
Aug 2018
Primary completion
Jun 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cyclosporine in renal artery stenosis (RAS), sponsored by Hospices Civils de Lyon. Started Aug 2018; status: completed.

02

Drugs

cyclosporine
03

Conditions

renal artery stenosis (RAS)

Beyond the preview

Go deeper on NCT03382301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03382301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call